View more on these topics

IFAs fear allocation backlash

Almost 60 per cent of IFAs fear regulatory backlash over their asset allocation decisions in the wake of recent stockmarket volatility, new research from MetLife Europe shows.

The survey of 100 advisers shows 41 per cent have plans in place to deal with any potential regulatory problems if their asset allocation advice is challenged but a further 18 per cent of those who have concerns have not taken action to deal with any potential complaints over losses in the wake of steep falls on stockmarkets.

MetLife has launched a series of masterclasses outlining how unit-linked guarantees can help in retirement planning and alleviate some concerns around asset allocation decisions.

Managing director Dominic Grinstead says: “Advisers are concerned that the unprecedented economic events will end in regulatory action against them and it is an understandable fear as it is certainly the case that clients have suffered.”

Recommended

Dying breed

It is clear from the announcements by Aviva and Legal & General that they have realised IFAs are no longer their willing salesforce and have decided to relaunch/grow their own tied salesforces. This is just the last breath of a dying breed that cannot realise the world has moved on without them.

Rise and fall

In the wake of the global economy’s almost complete halt at the end of last year, macroeconomic data is now showing signs of improvement. In recent months, global stock markets posted some of the strongest rallies on record. The consensus view has rapidly shifted to a strong economic recovery and fears over deflation have been cast aside.

Three stocks due a Brexit boost

By Mark Martin & Holly Cassell, Neptune Mark Martin and Holly Cassell highlight three high-conviction holdings in the Neptune UK Mid Cap Fund that they believe are well positioned to benefit from Brexit. Read more Important information Investment risks Neptune funds may have a high historic volatility rating and past performance is not a guide […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment